The bacterium Mycobacterium leprae or Mycobacterium lepromatous is the chronic infectious illness that causes Leprosy. The disease Hansen's is another name for leprosy. The human body's nerves, skin, eyes, mucosa (of the mouth, nose, and pharynx), kidneys, testicles, reticulo-endothelial system, and voluntary smooth muscles are the main organs affected by it. Leprosy Treatment Market include swollen or damaged nerves as well as numb skin sores. Paucibacillary and multibacillary leprosy are two broad categories for leprosy. Furthermore, paucibacillary leprosy is a diagnosis given to leprosy patients who have negative smear tests across the board (few skin lesions with or without the involvement of peripheral nerves).
Macleods Pharmaceuticals, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Sanofi S.A., Cadila Pharmaceuticals, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Eli Lily and Company, Bristol-Myers Squibb and Company, and Pfizer Inc. are a few of the major businesses profiles of the Leprosy Treatment Market.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/03/global-leprosy-treatment-market-is.html
